A multifaceted approach to RSV vaccination

References

• Anderson AJ, Snelling TL, Moore HC, Blyth CC. Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children. Paediatr Drugs. 2017;19(6):523–31. doi:10.1007/s40272-017-0257-x. PMID:28808938.
   PubMed Web of Science ®Google Scholar
• Anderson LJ. Respiratory syncytial virus vaccine development. Semin Immunol. 2013;25(2):160–71. doi:10.1016/j.smim.2013.04.011. PMID:23778071.
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine. 2013;31 Suppl 2, B209–215. doi:10.1016/j.vaccine.2012.11.106.
   PubMed Web of Science ®Google Scholar
• August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, Fries LF. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine. 2017;35(30):3749–59. doi:10.1016/j.vaccine.2017.05.045. PMID:28579233.
   PubMed Web of Science ®Google Scholar
• Beran J, Lickliter JD, Schwarz TF, Johnson C, Chu L, Domachowske JB, Dieussaert I. Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in non-pregnant women: results from two phase II trials. J Infect Dis. 2018;217(10):1616–25. doi:10.1093/infdis/jiy065. PMID:29401325.
   PubMed Web of Science ®Google Scholar
• Blais N, Gagne M, Hamuro Y, Rheault P, Boyer M, Steff AM, Martin D. Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation. J Virol. 2017;91(13). doi:10.1128/JVI.02437-16. PMID:28404847.
   PubMed Web of Science ®Google Scholar
• Blanco JCG, Pletneva LM, Otoa RO, Patel MC, Vogel SN, Boukhvalova MS. Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats. Vaccine. 2017;35(32):3951–8. doi:10.1016/j.vaccine.2017.06.009. PMID:28624306.
   PubMed Web of Science ®Google Scholar
• Blanco JC, Pletneva LM, Oue RO, Patel MC, Boukhvalova MS. Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy. Vaccine. 2015;33(41):5371–9. doi:10.1016/j.vaccine.2015.08.071. PMID:26335771.
   PubMed Web of Science ®Google Scholar
• Blodorn K, Hagglund S, Fix J, Dubuquoy C, Makabi-Panzu B, Thom M, Valarcher JF. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies. PLoS ONE. 2014;9(6), e100392. doi:10.1371/journal.pone.0100392. PMID:24945377.
   PubMed Web of Science ®Google Scholar
• Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med. 1997;102(3A):27–30; discussion 42-23. doi:10.1016/S0002-9343(97)00007-7. PMID:10868139.
   PubMedGoogle Scholar
• Branche AR, Falsey AR. Respiratory syncytial virus infection in older adults: an under-recognized problem. Drugs Aging. 2015;32(4):261–9. doi:10.1007/s40266-015-0258-9. PMID:25851217.
   PubMed Web of Science ®Google Scholar
• Brandenburg AH, Groen J, van Steensel-Moll HA, Claas EC, Rothbarth PH, Neijens HJ, Osterhaus AD. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection. J Med Virol. 1997;52(1):97–104. doi:10.1002/(SICI)1096-9071(199705)52:1%3c97::AID-JMV16%3e3.0.CO;2-Y. PMID:9131465.
   PubMed Web of Science ®Google Scholar
• Bueno SM, Gonzalez PA, Cautivo KM, Mora JE, Leiva ED, Tobar HE, Kalergis AM. Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG. Proc Natl Acad Sci U S A. 2008;105(52):20822–7. doi:10.1073/pnas.0806244105. PMID:19075247.
   PubMed Web of Science ®Google Scholar
• Buynak EB, Weibel RE, Carlson AJ, McLean AA, Hilleman MR. Further inestigation of live respiratory virus vaccine administered parenterally (40433). Proc Soc Exp Biol Med. 1979;160:272–7. doi:10.3181/00379727-160-40433.
   PubMed Web of Science ®Google Scholar
• Capella C, Chaiwatpongsakorn S, Gorrell E, Risch ZA, Ye F, Mertz SE, Peeples ME. Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. J Infect Dis. 2017;216(11):1398–406. doi:10.1093/infdis/jix489. PMID:29029312.
   PubMed Web of Science ®Google Scholar
• Cautivo KM, Bueno SM, Cortes CM, Wozniak A, Riedel CA, Kalergis AM. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guerin promotes virus clearance and protects from infection. J Immunol. 2010;185(12):7633–45. doi:10.4049/jimmunol.0903452. PMID:21084664.
   PubMed Web of Science ®Google Scholar
• Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969;89(4):449–63. doi:10.1093/oxfordjournals.aje.a120957. PMID:4305200.
   PubMed Web of Science ®Google Scholar
• Chu HY, Englund JA. Maternal immunization. Clin Infect Dis. 2014;59(4):560–8. doi:10.1093/cid/ciu327. PMID:24799324.
   PubMed Web of Science ®Google Scholar
• Chu HY, Katz J, Tielsch J, Khatry SK, Shrestha L, LeClerq SC, Englund JA. Clinical Presentation and Birth Outcomes Associated with Respiratory Syncytial Virus Infection in Pregnancy. PLoS ONE. 2016;11(3), e0152015. doi:10.1371/journal.pone.0152015. PMID:27031702.
   PubMed Web of Science ®Google Scholar
• Collins PL, Crowe JE. Respiratory syncytial virus and metapneumovirus. (5th ed. Vol. 2). Philadelphia: Lippincott-Williams & Wilkins; 2007
   Google Scholar
• Corti D, Bianchi S, Vanzetta F, Minola A, Perez L, Agatic G, Lanzavecchia A. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature. 2013;501(7467):439–43. doi:10.1038/nature12442. PMID:23955151.
   PubMed Web of Science ®Google Scholar
• Crowe JE, Jr., Williams JV. Immunology of viral respiratory tract infection in infancy. Paediatr Respir Rev. 2003;4(2):112–9. doi:10.1016/S1526-0542(03)00033-2. PMID:12758048.
   PubMedGoogle Scholar
• Falloon J, Ji F, Curtis C, Bart S, Sheldon E, Krieger D, Esser MT. A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant. Vaccine. 2016;34(25):2847–54. doi:10.1016/j.vaccine.2016.04.002. PMID:27102821.
   PubMed Web of Science ®Google Scholar
• Falloon J, Talbot HK, Curtis C, Ervin J, Krieger D, Dubovsky F, Esser MT. Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses. Clin Vaccine Immunol. 2017;24(9):e00157–17. doi:10.1128/CVI.00157-17. PMID:28679495
   PubMed Web of Science ®Google Scholar
• Falloon J, Yu J, Esser MT, Villafana T, Yu L, Dubovsky F, Falsey AR. An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults. J Infect Dis. 2017;216(11):1362–70. doi:10.1093/infdis/jix503. PMID:29029260.
   PubMed Web of Science ®Google Scholar
• Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005;22(7):577–87. doi:10.2165/00002512-200522070-00004. PMID:16038573.
   PubMed Web of Science ®Google Scholar
• Feldman AS, He Y, Moore ML, Hershenson MB, Hartert TV. Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma. Am J Respir Crit Care Med. 2015;191(1):34–44. doi:10.1164/rccm.201405-0901PP. PMID:25369458.
   PubMed Web of Science ®Google Scholar
• Fries L, Shinde V, Stoddard JJ, Thomas DN, Kpamegan E, Lu H, Glenn GM. Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults. Immun Ageing. 2017;14:8. doi:10.1186/s12979-017-0090-7. PMID:28413427.
   PubMed Web of Science ®Google Scholar
• Fulginiti VA, Eller JJ, Sieber OF, Joyner JW, Minamitani M, Meiklejohn G. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol. 1969;89(4):435–48. doi:10.1093/oxfordjournals.aje.a120956. PMID:4305199.
   PubMed Web of Science ®Google Scholar
• Garg R, Latimer L, Wang Y, Simko E, Gerdts V, Potter A, van Drunen Littel-van den Hurk S. Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs. Vaccine. 2016;34(2):261–9. doi:10.1016/j.vaccine.2015.11.029. PMID:26616551.
   PubMed Web of Science ®Google Scholar
• Glenn GM, Fries LF, Smith G, Kpamegan E, Lu H, Guebre-Xabier M, Flyer D. Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs. Vaccine. 2015;33(47):6488–92. doi:10.1016/j.vaccine.2015.08.039. PMID:26319066.
   PubMed Web of Science ®Google Scholar
• Glenn GM, Fries LF, Thomas DN, Smith G, Kpamegan E, Lu H, Piedra PA. A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age. J Infect Dis. 2016;213(3):411–22. doi:10.1093/infdis/jiv406. PMID:26259809.
   PubMed Web of Science ®Google Scholar
• Glenn GM, Smith G, Fries L, Raghunandan R, Lu H, Zhou B, Piedra PA. Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine. Vaccine. 2013;31(3):524–32. doi:10.1016/j.vaccine.2012.11.009. PMID:23153449.
   PubMed Web of Science ®Google Scholar
• Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98(5):708–15. doi:10.1016/S0022-3476(81)80829-3. PMID:7229749.
   PubMed Web of Science ®Google Scholar
• Green CA, Scarselli E, Sande CJ, Thompson AJ, de Lara CM, Taylor KS, Pollard AJ. Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. Sci Transl Med. 2015;7(300):300ra126. doi:10.1126/scitranslmed.aac5745. PMID:26268313.
   PubMed Web of Science ®Google Scholar
• Green CA, Scarselli E, Voysey M, Capone S, Vitelli A, Nicosia A, Pollard AJ. Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults. BMJ Open. 2015;5(10), e008748. doi:10.1136/bmjopen-2015-008748. PMID:26510727.
   PubMed Web of Science ®Google Scholar
• Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991;163(4):693–8. doi:10.1093/infdis/163.4.693. PMID:2010624.
   PubMed Web of Science ®Google Scholar
• Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360(6):588–98. doi:10.1056/NEJMoa0804877. PMID:19196675.
   PubMed Web of Science ®Google Scholar
• Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis. 1999;179(1):25–30. doi:10.1086/314567. PMID:9841818.
   PubMed Web of Science ®Google Scholar
• Harrington RD, Hooton TM, Hackman RC, Storch GA, Osborne B, Gleaves CA, Meyers JD. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165(6):987–93. doi:10.1093/infdis/165.6.987. PMID:1583345.
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Valkonen H, Waris M, Ruuskanen O. Transmission of respiratory syncytial virus infection within families. Open Forum Infect Dis. 2015;2(1), ofu118. doi:10.1093/ofid/ofu118. PMID:25884006.
   PubMed Web of Science ®Google Scholar
• Henderson FW, Collier AM, Clyde WA, Jr., Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979;300(10):530–4. doi:10.1056/NEJM197903083001004. PMID:763253.
   PubMed Web of Science ®Google Scholar
• Higgins D, Trujillo C, Keech C. Advances in RSV vaccine research and development – A global agenda. Vaccine. 2016;34(26):2870–5. doi:10.1016/j.vaccine.2016.03.109. PMID:27105562.
   PubMed Web of Science ®Google Scholar
• Kaaijk P, Luytjes W, Rots NY. Vaccination against RSV: is maternal vaccination a good alternative to other approaches? Hum Vaccin Immunother. 2013;9(6):1263–7. doi:10.4161/hv.24096. PMID:23442726.
   PubMed Web of Science ®Google Scholar
• Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969;89(4):405–21. doi:10.1093/oxfordjournals.aje.a120954. PMID:4305197.
   PubMed Web of Science ®Google Scholar
• Karron RA, Buchholz UJ, Collins PL. Live-attenuated respiratory syncytial virus vaccines. Curr Top Microbiol Immunol. 2013;372:259–84. doi:10.1007/978-3-642-38919-1_13.
   PubMed Web of Science ®Google Scholar
• Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, Parrott RH. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol. 1969;89(4):422–34. doi:10.1093/oxfordjournals.aje.a120955. PMID:4305198.
   PubMed Web of Science ®Google Scholar
• Kim L, Martinez CJ, Hodgson KA, Trager GR, Brandl JR, Sandefer EP, Doll WJ, Liebowitz D, Tucker SN. Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule. Scientific Reports 2016;6:37295 DOI: doi:10.1038/srep37295. PMID:27881837.
   PubMed Web of Science ®Google Scholar
• Lambert SL, Aslam S, Stillman E, MacPhail M, Nelson C, Ro B, Tang RS. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models. PLoS ONE. 2015;10(3), e0119509. doi:10.1371/journal.pone.0119509. PMID:25793508.
   PubMed Web of Science ®Google Scholar
• Lambert SL, Yang CF, Liu Z, Sweetwood R, Zhao J, Cheng L, Woo J. Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A. PLoS ONE. 2012;7(12), e51618. doi:10.1371/journal.pone.0051618. PMID:23284726.
   PubMed Web of Science ®Google Scholar
• Langley JM, Aggarwal N, Toma A, Halperin SA, McNeil SA, Fissette L, Dieussaert I. A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant. J Infect Dis. 2017;215(1):24–33. doi:10.1093/infdis/jiw453. PMID:27694633.
   PubMed Web of Science ®Google Scholar
• Langley J, MacDonald L, Weir G, Mackinnon-Cameron D, Math M, Ye L, Halperin SA. A Phase I Randomized, observer-blind controlled, dose escalation trial of the safety and tolerability of two intramuscular doses of DPX-RSV(A), a respiratory syncytial virus (RSV) vaccine containing RSV SH antigen and a noveladjuvant DepoVax, or SH antigen co-administered with alum hydorxide or placebo to healthy adults >50-64 years of age. Open Forum of Infectious Disease. 2016;3(Suppl-1):1270.
   Google Scholar
• Magro M, Mas V, Chappell K, Vazquez M, Cano O, Luque D, Palomo C. Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention. Proc Natl Acad Sci U S A. 2012;109(8):3089–94. doi:10.1073/pnas.1115941109. PMID:22323598.
   PubMed Web of Science ®Google Scholar
• Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996;36(5):248–55. doi:10.1111/j.1600-0897.1996.tb00172.x. PMID:8955500.
   PubMed Web of Science ®Google Scholar
• McLellan JS. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr Opin Virol. 2015;11:70–75. doi:10.1016/j.coviro.2015.03.002.
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Joyce MG, Sastry M, Stewart-Jones GB, Yang Y, Kwong PD. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science. 2013;342(6158):592–8. doi:10.1126/science.1243283. PMID:24179220.
   PubMed Web of Science ®Google Scholar
• McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Graham BS. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science. 2013;340(6136):1113–7. doi:10.1126/science.1234914. PMID:23618766.
   PubMed Web of Science ®Google Scholar
• Munoz FM. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy? Curr Opin Infect Dis. 2015;28(3):221–4. doi:10.1097/QCO.0000000000000161. PMID:25918956.
   PubMed Web of Science ®Google Scholar
• Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine. 2003;21(24):3465–7. doi:10.1016/S0264-410X(03)00352-9. PMID:12850361.
   PubMed Web of Science ®Google Scholar
• Munywoki PK, Koech DC, Agoti CN, Lewa C, Cane PA, Medley GF, Nokes DJ. The source of respiratory syncytial virus infection in infants: a household cohort study in rural Kenya. J Infect Dis. 2014;209(11):1685–92. doi:10.1093/infdis/jit828. PMID:24367040.
   PubMed Web of Science ®Google Scholar
• Murphy BR, Alling DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WJ, Kim HW, Graham BS, et al.. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol. 1986;24(5):894–8. PMID:3771779.
   PubMed Web of Science ®Google Scholar
• Murphy BR, Olmsted RA, Collins PL, Chanock RM, Prince GA. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J Virol. 1988;62(10):3907–10. PMID:3047432.
   PubMed Web of Science ®Google Scholar
• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, Huda T. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children. Lancet. 2010;375(9725):1545–55. doi:10.1016/S0140-6736(10)60206-1. PMID:20399493.
   PubMed Web of Science ®Google Scholar
• Nandapalan N, Taylor CE, Greenwell J, Scott M, Scott R, Hey EN, Toms GL. Seasonal variations in maternal serum and mammary immunity to RS virus. J Med Virol. 1986;20(1):79–87. doi:10.1002/jmv.1890200110. PMID:3760842.
   PubMed Web of Science ®Google Scholar
• Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Graham BS. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci Transl Med. 2015;7(309):309ra162. doi:10.1126/scitranslmed.aac4241. PMID:26468324.
   PubMed Web of Science ®Google Scholar
• Nyiro JU, Kombe IK, Sande CJ, Kipkoech J, Kiyuka PK, Onyango CO, Nokes DJ. Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya. PLoS ONE. 2017;12(5):e0177803. doi:10.1371/journal.pone.0177803. PMID:28531224.
   PubMed Web of Science ®Google Scholar
• Ochola R, Sande C, Fegan G, Scott PD, Medley GF, Cane PA, Nokes DJ. The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLoS ONE. 2009;4(12):e8088. doi:10.1371/journal.pone.0008088. PMID:19956576.
   PubMed Web of Science ®Google Scholar
• Ohuma EO, Okiro EA, Ochola R, Sande CJ, Cane PA, Medley GF, Nokes DJ. The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease. Am J Epidemiol. 2012;176(9):794–802. doi:10.1093/aje/kws257. PMID:23059788.
   PubMed Web of Science ®Google Scholar
• The Impact-RSV Study Group. Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants. Pediatrics. 1998;102(3):531–7. doi:10.1542/peds.102.3.531.
   Web of Science ®Google Scholar
• Pierantoni A, Esposito ML, Ammendola V, Napolitano F, Grazioli F, Abbate A, Vitelli A. Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates. Mol Ther Methods Clin Dev. 2015;2:15018. doi:10.1038/mtm.2015.18. PMID:26015988.
   PubMed Web of Science ®Google Scholar
• Poletti P, Merler S, Ajelli M, Manfredi P, Munywoki PK, Nokes D, Melegaro A. Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings. BMC Med. 2015;13(1):49. doi:10.1186/s12916-015-0283-x. PMID:25857701.
   PubMed Web of Science ®Google Scholar
• Prince GA, Horswood RL, Camargo E, Suffin SC, Chanock RM. Parenteral immunization with live respiratory syncytial virus is blocked in seropositive cotton rats. Infect Immun. 1982;37(3):1074–8. PMID:6752019.
   PubMed Web of Science ®Google Scholar
• Prince GA, Potash L, Horswood RL, Camargo E, Suffin SC, Johnson RA, Chanock RM. Intramuscular inoculation of live respiratory syncytial virus induces immunity in cotton rats. Infect Immun. 1979;23(3):723–8. PMID:572342.
   PubMed Web of Science ®Google Scholar
• Raghunandan R, Lu H, Zhou B, Xabier MG, Massare MJ, Flyer DC, Glenn GM. An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization. Vaccine. 2014;32(48):6485–92. doi:10.1016/j.vaccine.2014.09.030. PMID:25269094.
   PubMed Web of Science ®Google Scholar
• The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group. Pediatrics. 1997;99(1):93–99. doi:10.1542/peds.99.1.93. PMID:8989345.
   PubMed Web of Science ®Google Scholar
• Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, de Haan CA. A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles. PLoS ONE. 2013;8(8):e71072. doi:10.1371/journal.pone.0071072. PMID:23951084.
   PubMed Web of Science ®Google Scholar
• Ruckwardt TJ, Morabito KM, Graham BS. Determinants of early life immune responses to RSV infection. Curr Opin Virol. 2016;16:151–7. doi:10.1016/j.coviro.2016.01.003. PMID:26986236.
   PubMed Web of Science ®Google Scholar
• Sastry M, Zhang B, Chen M, Joyce MG, Kong WP, Chuang GY, Kwong PD. Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus. PLoS ONE. 2017;12(10), e0186854. doi:10.1371/journal.pone.0186854. PMID:29073183.
   PubMed Web of Science ®Google Scholar
• Scallan CD, Lindbloom JD, Tucker SN. Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice. Infect Dis Ther. 2016;5(2):165–83. doi:10.1007/s40121-016-0108-z. PMID:27071663.
   PubMed Web of Science ®Google Scholar
• Scallan CD, Tingley DW, Lindbloom JD, Toomey JS, Tucker SN. An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models. Clin Vaccine Immunol. 2013;20(1):85–94. doi:10.1128/CVI.00552-12. PMID:23155123.
   PubMed Web of Science ®Google Scholar
• Schepens B, Sedeyn K, Vande Ginste L, De Baets S, Schotsaert M, Roose K, Saelens X. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein. EMBO Mol Med. 2014;6(11):1436–54. doi:10.15252/emmm.201404005. PMID:25298406.
   PubMed Web of Science ®Google Scholar
• Schneider-Ohrum K, Cayatte C, Bennett AS, Rajani GM, McTamney P, Nacel K, McCarthy MP. Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant. J Virol. 2017;91(8):e02180–16. doi:10.1128/JVI.02180-16. PMID:28659488
   PubMed Web of Science ®Google Scholar
• Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis. 2001;183(1);16–22. doi:10.1086/317655. PMID:11076709.
   PubMed Web of Science ®Google Scholar
• Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, Network RSV. Global Epidemiology. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017;390(10098):946–58. doi:10.1016/S0140-6736(17)30938-8. PMID:28689664.
   PubMed Web of Science ®Google Scholar
• Siber GR, Leszcynski J, Pena-Cruz V, Ferren-Gardner C, Anderson R, Hemming VG, Walsh EE, Burns J, McIntosh K, Gonin R, et al. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis. 1992;165(3):456–63. doi:10.1093/infdis/165.3.456. PMID:1538152.
   PubMed Web of Science ®Google Scholar
• Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143(5 Suppl), S118–126. doi:10.1067/S0022-3476(03)00511-0. PMID:14615710.
   PubMed Web of Science ®Google Scholar
• Smith G, Raghunandan R, Wu Y, Liu Y, Massare M, Nathan M, Glenn G. Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats. PLoS ONE. 2012;7(11), e50852. doi:10.1371/journal.pone.0050852. PMID:23226404.
   PubMed Web of Science ®Google Scholar
• Steff AM, Monroe J, Friedrich K, Chandramouli S, Nguyen TL, Tian S, Carfi A. Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV. Nat Commun. 2017;8(1):1085. doi:10.1038/s41467-017-01092-4. PMID:29057917.
   PubMed Web of Science ®Google Scholar
• Taylor G, Thom M, Capone S, Pierantoni A, Guzman E, Herbert R, Vitelli A. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections. Sci Transl Med. 2015;7(300):300ra127. doi:10.1126/scitranslmed.aac5757. PMID:26268314.
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–86. doi:10.1001/jama.289.2.179. PMID:12517228.
   PubMed Web of Science ®Google Scholar
• Trento A, Rodriguez-Fernandez R, Gonzalez-Sanchez MI, Gonzalez-Martinez F, Mas V, Vazquez M, Melero JA. The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years. Front Microbiol. 2017;8:2301. doi:10.3389/fmicb.2017.02301. PMID:29213258.
   PubMed Web of Science ®Google Scholar
• Wheeler SM, Dotters-Katz S, Heine RP, Grotegut CA, Swamy GK. Maternal Effects of Respiratory Syncytial Virus Infection during Pregnancy. Emerg Infect Dis. 2015;21(11):1951–5. doi:10.3201/eid2111.150497. PMID:26485575.
   PubMed Web of Science ®Google Scholar
• Widjojoatmodjo MN, Bogaert L, Meek B, Zahn R, Vellinga J, Custers J, Schuitemaker H. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats. Vaccine. 2015;33(41):5406–14. doi:10.1016/j.vaccine.2015.08.056. PMID:26319741.
   PubMed Web of Science ®Google Scholar